Grim statistics Pharma research and development , which is only 30 % of drugs in development actually make it all the way through the often more than eight years of development , to generate product revenue . With R & D Pharma project will cost an average of more than half a billion dollars (everything measured in dollars in the Pharma industry ) , which means making drugs generate income means that you have to invest U.S. $ 1.5 billion .
After a successful drug is produced , it does have a license patent for 20 years , in which the developer also has one of the sub – license is the most important , so that the delivery of drugs to the health industry can be considered safe . This means that the return on R & D costs alone , plus interest , the drug should produce $ 100 million per year in revenues , especially sales and distribution costs , effective R & D costs to pay back . This business model is not sustainable .
New business models Pharma
Now the human genome has developed . Needs and opportunities of new drugs faster graphics There are too many potential new projects and products resulting from large pharmaceutical companies to invest in , so what do they do?
Second , capital investment raised for the new opportunities in the pharmaceutical market . They are quite happy with the results of 30 % based on the company , which is often better than they received to invest in sectors lower – performing .
Third , in the old model , there is a glass ceiling problem . With R & D facilities are very large , the opportunity for career development in your chosen field has certain limitations . Now , if you have a passion for a particular type of disease or health , and you have the basic information material for your research , you can begin .
The result is that there are hundreds of new pharmaceutical company , backed by venture capitalists enthusiastic , there will be a few of them succeed and some not in finding new drugs . Those who helped develop successful products with both type approval and the sale and distribution needs , and thus can be invested in or sold to major pharmaceutical companies traditionally , which now has a much lower risk of their investment .
See pharma recruitment uk for more info about pharma UK.